04/05/2024
3:55 PM | Kinnate Biopharma (Issuer)
Meltz Mark A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2024
3:55 PM | DeSimone Jill (Reporting)
Kinnate Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2024
3:55 PM | Kinnate Biopharma (Issuer)
Sabzevari Helen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2024
3:55 PM | Kinnate Biopharma (Issuer)
Rome Michael E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2024
3:55 PM | Flaherty Keith T. (Reporting)
Kinnate Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2024
3:55 PM | Epperly Melissa B, (Reporting)
Kinnate Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2024
3:55 PM | Kinnate Biopharma (Issuer)
Smaldone Alsup Laurie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
04/05/2024
3:55 PM | Kinnate Biopharma (Issuer)
Krishnamohan Neha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2024
3:55 PM | Kinnate Biopharma (Issuer)
MITCHELL DEAN J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2024
3:55 PM | Farzan Nima (Reporting)
Kinnate Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2024
3:55 PM | Kinnate Biopharma (Issuer)
Tananbaum James B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2024
3:39 PM | GORDON CARL L (Reporting)
Kinnate Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2024
3:33 PM | Kinnate Biopharma (Issuer)
OrbiMed Advisors IV Ltd (Reporting)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Asia GP IV, L.P. (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
OrbiMed Capital GP VIII LLC (Reporting)
ORBIMED CAPITAL LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2024
3:15 PM | Foresite Capital Fund V, L.P. (Filed by)
Kinnate Biopharma (Subject)
| Form SC 13D/A | |
04/05/2024
1:15 PM | Foresite Capital Fund IV, L.P. (Reporting)
Foresite Capital Fund V, L.P. (Reporting)
Foresite Capital Management IV, LLC (Reporting)
Foresite Capital Management V, LLC (Reporting)
Foresite Capital Opportunity Fund V, L.P. (Reporting)
Foresite Capital Opportunity Management V, LLC (Reporting)
Kinnate Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
4:23 PM | Kinnate Biopharma (Filer)
| Form S-8 POS | |
04/03/2024
4:25 PM | Kinnate Biopharma (Filer)
| Form S-8 POS | |
04/03/2024
4:28 PM | Kinnate Biopharma (Filer)
| Form S-8 POS | |
04/03/2024
8:28 AM | Kinnate Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/03/2024
8:06 AM | Kinnate Biopharma (Subject)
XOMA Corp (Filed by)
XOMA Corp (Filed by)
XOMA Corp (Filed by)
| Form SC TO-T/A | |
04/03/2024
8:09 AM | Kinnate Biopharma (Subject)
Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
04/03/2024
8:13 AM | Kinnate Biopharma (Subject)
| Form SC 14D9/A | |
03/22/2024
4:14 PM | Kinnate Biopharma (Subject)
| Form SC 14D9/A | |
03/01/2024
7:50 AM | Kinnate Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
7:53 AM | Kinnate Biopharma (Subject)
| Form SC14D9C | |
02/27/2024
3:42 PM | Kinnate Biopharma (Subject)
XOMA Corp (Filed by)
XOMA Corp (Filed by)
XOMA Corp (Filed by)
| Form SC TO-C | |
02/22/2024
3:39 PM | Foresite Capital Fund V, L.P. (Filed by)
Kinnate Biopharma (Subject)
| Form SC 13D/A | |
02/21/2024
5:01 AM | Kinnate Biopharma (Subject)
| Form SC14D9C | |
02/16/2024
8:10 AM | Kinnate Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
8:21 AM | Kinnate Biopharma (Subject)
Lynx1 Capital Management LP (Filed by)
| Form SC 13G/A | |
11/17/2023
7:27 AM | Kinnate Biopharma (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13D/A | |
11/17/2023
7:00 AM | Foresite Capital Fund V, L.P. (Filed by)
Kinnate Biopharma (Subject)
| Form SC 13D/A | |
11/15/2023
8:00 AM | Kinnate Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
3:21 PM | Kinnate Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/18/2023
3:28 PM | Kinnate Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/06/2023
4:00 PM | Kinnate Biopharma (Issuer)
Williams Richard Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
4:00 PM | Kinnate Biopharma (Issuer)
Meltz Mark A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
4:00 PM | Kinnate Biopharma (Issuer)
Krishnamohan Neha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
5:26 PM | Epperly Melissa B, (Reporting)
Kinnate Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
5:28 PM | Flaherty Keith T. (Reporting)
Kinnate Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
5:29 PM | GORDON CARL L (Reporting)
Kinnate Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
My top 100 stocks… (Ad) We recently ran an internal audit of every trade recommendation I’ve published across all my services…
And let me tell ya, we found some incredible insights…
For starters, we found about 100 stocks I trade really, really well. Get some cool freebies right here. |
06/13/2023
5:30 PM | Kinnate Biopharma (Issuer)
MITCHELL DEAN J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
5:31 PM | Kinnate Biopharma (Issuer)
Smaldone Alsup Laurie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
5:32 PM | Kinnate Biopharma (Issuer)
Sabzevari Helen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
4:00 PM | Kinnate Biopharma (Issuer)
Krishnamohan Neha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
4:00 PM | Kinnate Biopharma (Issuer)
Meltz Mark A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
4:01 PM | Kinnate Biopharma (Issuer)
Williams Richard Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2023
4:42 PM | Foresite Capital Fund IV, L.P. (Reporting)
Foresite Capital Fund V, L.P. (Reporting)
Foresite Capital Management IV, LLC (Reporting)
Foresite Capital Management V, LLC (Reporting)
Foresite Capital Opportunity Fund V, L.P. (Reporting)
Foresite Capital Opportunity Management V, LLC (Reporting)
Kinnate Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2023
4:49 PM | Kinnate Biopharma (Issuer)
Tananbaum James B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2023
4:20 PM | Foresite Capital Fund IV, L.P. (Filed by)
Kinnate Biopharma (Subject)
| Form SC 13D/A | |
05/08/2023
4:22 PM | Kinnate Biopharma (Issuer)
OrbiMed Advisors IV Ltd (Reporting)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Asia GP IV, L.P. (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
OrbiMed Capital GP VIII LLC (Reporting)
ORBIMED CAPITAL LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
8:38 PM | GORDON CARL L (Reporting)
Kinnate Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
8:34 PM | Kinnate Biopharma (Issuer)
OrbiMed Advisors IV Ltd (Reporting)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Asia GP IV, L.P. (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
OrbiMed Capital GP VIII LLC (Reporting)
ORBIMED CAPITAL LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
